Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
18 Apr 2026
PR Newswire Association LLC.
Prof. Dr. Wilhelm Haverkamp Appointed Chief Medical Officer at SCIRENT
16 Apr 2026
GlobeNewswire
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
16 Apr 2026
GlobeNewswire
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026
16 Apr 2026
GlobeNewswire
Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
15 Apr 2026
PR Newswire Association LLC.
HIKMICRO Strengthens Instrumentation Push with LRG10 Series Radar Level Meter
15 Apr 2026
GlobeNewswire
Alira Health and Autoimmune Neurology Alliance (AiNA) Launch AXIS Registry, Advancing Real-World and Patient-Centered Research in Autoimmune Neurology
15 Apr 2026
GlobeNewswire
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
15 Apr 2026
GlobeNewswire
Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered
14 Apr 2026
GlobeNewswire
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
14 Apr 2026
PR Newswire Association LLC.
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
14 Apr 2026
GlobeNewswire
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
13 Apr 2026
PR Newswire Association LLC.
Ada Health Patents the Clinical Layer That Makes LLMs Safe for Healthcare
13 Apr 2026
PR Newswire Association LLC.
"In Europe, For Europe": Haier Biomedical Spotlights Full-Scenario Lab Solutions at analytica Munich 2026
10 Apr 2026
GlobeNewswire
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
09 Apr 2026
GlobeNewswire
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
09 Apr 2026
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
09 Apr 2026
PR Newswire Association LLC.
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
09 Apr 2026
PR Newswire Association LLC.
Largest Clinical Study of XyliMelts® Shows Significant Relief for Dry Mouth While Sleeping
08 Apr 2026
PR Newswire Association LLC.
ZEISS advances connected cataract and refractive workflows with new digital, AI and surgical innovations at ASCRS
02 Apr 2026
PR Newswire Association LLC.
NUHS CHARTS NEW ERA OF PERSONALISED CARE WITH GENOMICS AND DATA-GUIDED BREAKTHROUGHS
02 Apr 2026
PR Newswire Association LLC.
Peri Launches First Wearable Device Designed Specifically for Perimenopause
02 Apr 2026
PR Newswire Association LLC.
Bebird Launches EarSight Ultra : The 5G-Powered Ear Care Solution for Modern Families Pursuing a Quality Life
01 Apr 2026
PR Newswire Association LLC.
Wegovy®▼(semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥27 kg/m2)[1]
01 Apr 2026
Upcoming Events All Events
- April 2026
- Seattle: Life Science Innovation Northwest 2026
- Leipzig: German Biotech Days
- Shanghai: ChinaBio® Partnering Forum